Search result for:


Cell Line: LNCaP
Cell Type: epithelial Prostate
Description:  Human prostata adenocarcinoma
other names: LNCaP
application: miRNA
Recommendation:  ScreenFect siRNA

Recommendation based on in-house testing or customer feedback.

Recommendation based on the characteristics of ScreenFect transfection reagents.





Recommendation:  ScreenFect®siRNA

Transfection conditions*


Format: 96-well 24-well 6-well
ScreenFect volume: 0,25 µl 1 µl 4 µl
Amount of nucleic acid: 1 pmol 5 pmol 25 pmol
       
Cell number (cells/well) - - -
* The values given refer to the recommended One-Step method.
See our manual for further details: Download Manual
       
Transfection efficiency: - - -
Viability: - - -
       
ScreenFect Enhacer addition leads to the following results:      
Transefction efficiency increase:      

* The values given refer to the recommended One-Step method. 
See our manual for further details: Download Manual



ScreenFect_A-Aplus_neu_5.jpg




Alternative product:  ScreenFect®A


Format: 96-well 24-well 6-well
ScreenFect volume: 0,3 µl 1,8 µl 6 µl
Amount of nucleic acid: 1 pmol 5 pmol 25 pmol
       
Cell number (cells/well) 30.000 - -
* The values given refer to the recommended One-Step method.
See our manual for further details: Download Manual
       
Transfection efficiency: - - -
Viability: - - -
       
ScreenFect Enhacer addition leads to the following results:      
Transefction efficiency increase:      

* The values given refer to the recommended One-Step method. 
See our manual for further details: Download Manual



ScreenFect_A-Aplus_neu_4.jpg

ScreenFect GmbH • Hermann-von-Helmholtz-Platz 1 • D-76344 Eggenstein-Leopoldshafen • Tel: +49-721-608-29113 • Email: SiMkLCUKOSk4Ly8kLC8pPmQpJSc@nospam

empty